Arizona Oncology Associates

Sedona, Arizona 86336

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, ER, Estrogen Receptor Positive, Gastroenteropancreatic Neuroendocrine Tumors, HER2, HER2 Positive, MBC, Metastatic Breast Cancer, Non Small Cell Lung Cancer (NSCLC), Triple Negative

Studies at this site

• A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen — Completed
• Community-based Neuroendocrine Tumor (NET) Research Study — Completed
• A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer — Stopped early